Perspectives

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Decorative yellow brand motif
Guidemark Health is Committed to Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal disease of the pulmonary arteries. Patients with PAH face hurdles common to those with rare diseases, including finding accurate disease information, identifying healthcare professionals (HCPs) with the right expertise, getting a timely and correct diagnosis, and receiving appropriate treatment.
View Feb 25, 2022
Modeling To Inform Payer Communications and Policy – Optimizing Treatment Sequences in Multiple Immunology Indications
Health systems view low-cost therapeutic alternatives (biosimilars and generics) as opportunities to reduce their medicine spend. However, this approach focuses on costs only and not outcomes, which results in the adoption of ‘low-cost first’ blanket policies regardless of biologic class or therapy area. Consequently, patients are left to cycle through low-cost options before they can access the most effective treatments
Case Study Feb 18, 2022
Syndicated Offerings: Sonar & Engage
Our newly developed syndicated research program is designed to assist in meeting your strategic objectives at key stages of product lifecycle, building upon our extensive experience in both the digital and healthcare space.
Resource